We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.08B
AUM Growth
+$312M
(+4.6%)
Cap. Flow
+$423M
Cap. Flow
% of AUM
5.97%
Top 10 Holdings %
Top 10 Hldgs %
31.95%
Holding
1,367
New
348
Increased
332
Reduced
294
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$188M |
| 2 |
Labcorp
LH
|
+$183M |
| 3 |
AGN
Allergan Inc
AGN
|
+$144M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$93.8M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$82.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookdale Senior Living
BKD
|
+$104M |
| 2 |
Cardinal Health
CAH
|
+$104M |
| 3 |
AGN
Allergan plc
AGN
|
+$80.7M |
| 4 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$60.3M |
| 5 |
Elevance Health
ELV
|
+$55.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.3% |
| 2 | Consumer Discretionary | 5.38% |
| 3 | Financials | 4.49% |
| 4 | Industrials | 3.37% |
| 5 | Technology | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Amdocs
DOX
$5.92B
| $274K | ﹤0.01% |
+5,860
| New | +$275K |
|
|
HES
877
DELISTED
Hess
HES
| $274K | ﹤0.01% |
3,708
-227,709
| -98% | -$18M |
|
878
Hanover Insurance
THG
$8.1B
| $274K | ﹤0.01% |
+3,840
| New | +$260K |
|
879
CoStar Group
CSGP
$11.7B
| $273K | ﹤0.01% |
+14,860
| New | +$240K |
|
880
UGI
UGI
$7.74B
| $273K | ﹤0.01% |
+7,170
| New | +$264K |
|
881
FMC
FMC
$1.34B
| $272K | ﹤0.01% |
5,485
-36,935
| -87% | -$1.8M |
|
|
MWIV
882
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
| $272K | ﹤0.01% |
+1,600
| New | +$256K |
|
|
MTOR
883
DELISTED
MERITOR, Inc.
MTOR
| $270K | ﹤0.01% |
17,780
-16,317
| -48% | -$207K |
|
|
CELG
884
DELISTED
Celgene Corp
CELG
| $269K | ﹤0.01% |
+2,400
| New | +$253K |
|
885
Southern Copper
SCCO
$143B
| $266K | ﹤0.01% |
10,140
-221,302
| -96% | -$5.97M |
|
|
SNBR
886
DELISTED
Sleep Number
SNBR
| $265K | ﹤0.01% |
+9,770
| New | +$243K |
|
|
CNW
887
DELISTED
CON-WAY INC.
CNW
| $265K | ﹤0.01% |
5,370
-1,520
| -22% | -$70.3K |
|
888
Western Union
WU
$1.99B
| $262K | ﹤0.01% |
14,600
-7,177
| -33% | -$124K |
|
889
Domino's
DPZ
$11.5B
| $261K | ﹤0.01% |
+2,766
| New | +$248K |
|
890
Novartis
NVS
$297B
| $260K | ﹤0.01% |
3,125
-19,548
| -86% | -$1.62M |
|
|
PCYC
891
DELISTED
PHARMACYCLICS INC
PCYC
| $260K | ﹤0.01% |
+2,122
| New | +$271K |
|
892
Mastercard
MA
$506B
| $258K | ﹤0.01% |
+2,984
| New | +$244K |
|
|
NLSN
893
DELISTED
Nielsen Holdings plc
NLSN
| $258K | ﹤0.01% |
+5,764
| New | +$247K |
|
|
ARUN
894
DELISTED
ARUBA NETWORKS, INC.
ARUN
| $258K | ﹤0.01% |
14,142
-86,869
| -86% | -$1.73M |
|
895
Encore Capital Group
ECPG
$2.02B
| $256K | ﹤0.01% |
+5,750
| New | +$247K |
|
896
Tapestry
TPR
$30.8B
| $256K | ﹤0.01% |
+6,800
| New | +$240K |
|
|
SCG
897
DELISTED
Scana
SCG
| $256K | ﹤0.01% |
+4,232
| New | +$234K |
|
898
Belden
BDC
$4.83B
| $254K | ﹤0.01% |
+3,216
| New | +$228K |
|
899
Interactive Brokers
IBKR
$39.2B
| $253K | ﹤0.01% |
+34,640
| New | +$232K |
|
900
B&G Foods
BGS
$287M
| $250K | ﹤0.01% |
+8,360
| New | +$243K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q4 2014 Portfolio in Review
As of Q4 2014, Visium Asset Management held 1,367 positions worth $7.08B, up 4.6% from $6.77B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $423M of net new capital in Q4 2014, opening 348 new positions and adding to 332 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Brookdale Senior Living, an estimated $104M trimmed.
- Visium Asset Management's largest Q4 2014 buy was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
- Visium Asset Management added most to COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, an estimated $188M increase.
- Visium Asset Management's biggest Q4 2014 reduction was Brookdale Senior Living, cutting an estimated $104M.
- Visium Asset Management fully exited AMAG Pharmaceuticals in Q4 2014, selling an estimated $60.3M.
- Visium Asset Management's ten largest holdings make up 32% of its $7.08B portfolio in Q4 2014.
- Visium Asset Management opened 348 new positions and closed 358 in Q4 2014.
- Visium Asset Management's portfolio value rose 4.6% quarter-over-quarter to $7.08B.
Based on Visium Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.